Confluence Investment Management LLC Gilead Sciences, Inc. Transaction History
Confluence Investment Management LLC
- $6.68 Billion
- Q1 2025
A detailed history of Confluence Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Confluence Investment Management LLC holds 979,976 shares of GILD stock, worth $111 Million. This represents 1.64% of its overall portfolio holdings.
Number of Shares
979,976
Previous 1,176,858
16.73%
Holding current value
$111 Million
Previous $109 Million
1.01%
% of portfolio
1.64%
Previous 1.57%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,287Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.3 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.73 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.17 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.05 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...